Published in J Infect Dis on April 01, 1993
Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors. BMJ (1995) 6.28
Chlamydia pneumoniae (TWAR). Clin Microbiol Rev (1995) 4.93
Modulation of atherosclerosis in mice by Toll-like receptor 2. J Clin Invest (2005) 3.91
Chlamydial persistence: beyond the biphasic paradigm. Infect Immun (2004) 2.78
Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells. Infect Immun (1996) 2.52
Comparison of whole genome sequences of Chlamydia pneumoniae J138 from Japan and CWL029 from USA. Nucleic Acids Res (2000) 2.16
Chlamydia pneumoniae (TWAR) in coronary arteries of young adults (15-34 years old). Proc Natl Acad Sci U S A (1995) 2.15
Chlamydial and human heat shock protein 60s activate human vascular endothelium, smooth muscle cells, and macrophages. J Clin Invest (1999) 2.13
Serological cross-reactions between Bartonella and Chlamydia species: implications for diagnosis. J Clin Microbiol (1997) 2.08
Detection of Chlamydia pneumoniae but not Helicobacter pylori in atherosclerotic plaques of aortic aneurysms. J Clin Microbiol (1996) 1.68
Chlamydia pneumoniae in arteries: the facts, their interpretation, and future studies. J Clin Pathol (1998) 1.64
Molecular diagnosis of Chlamydia pneumoniae infection. J Clin Microbiol (1999) 1.52
Antimicrobial susceptibility and therapy of infections caused by Chlamydia pneumoniae. Antimicrob Agents Chemother (1994) 1.49
Detection and widespread distribution of Chlamydia pneumoniae in the vascular system and its possible implications. J Clin Pathol (1996) 1.49
Multicenter comparison trial of DNA extraction methods and PCR assays for detection of Chlamydia pneumoniae in endarterectomy specimens. J Clin Microbiol (2001) 1.46
Chlamydia pneumoniae and atherosclerosis: critical assessment of diagnostic methods and relevance to treatment studies. Clin Microbiol Rev (2002) 1.45
Genomic relatedness of Chlamydia isolates determined by amplified fragment length polymorphism analysis. J Bacteriol (1999) 1.45
In vitro susceptibility of human vascular wall cells to infection with Chlamydia pneumoniae. J Clin Microbiol (1995) 1.45
Chlamydiae as pathogens: new species and new issues. Emerg Infect Dis (1997) 1.43
Rabbit model for Chlamydia pneumoniae infection. J Clin Microbiol (1997) 1.41
Detection of Treponema denticola in atherosclerotic lesions. J Clin Microbiol (2001) 1.31
Chlamydia pneumoniae infection induces inflammatory changes in the aortas of rabbits. Infect Immun (1997) 1.27
A Chlamydia pneumoniae component that induces macrophage foam cell formation is chlamydial lipopolysaccharide. Infect Immun (1998) 1.25
Specificity of detection of Chlamydia pneumoniae in cardiovascular atheroma: evaluation of the innocent bystander hypothesis. Am J Pathol (1997) 1.24
Identification of two novel genes encoding 97- to 99-kilodalton outer membrane proteins of Chlamydia pneumoniae. Infect Immun (1999) 1.22
TLR/MyD88 and liver X receptor alpha signaling pathways reciprocally control Chlamydia pneumoniae-induced acceleration of atherosclerosis. J Immunol (2008) 1.22
Comparison of Chlamydia pneumoniae isolates by western blot (immunoblot) analysis and DNA sequencing of the omp 2 gene. J Clin Microbiol (1994) 1.22
Chlamydia pneumoniae--induced macrophage foam cell formation is mediated by Toll-like receptor 2. Infect Immun (2006) 1.21
In vitro activities of azithromycin and ofloxacin against Chlamydia pneumoniae in a continuous-infection model. Antimicrob Agents Chemother (1999) 1.20
Roles of interleukin-12 and gamma interferon in murine Chlamydia pneumoniae infection. Infect Immun (2000) 1.18
Chlamydia pneumoniae expresses genes required for DNA replication but not cytokinesis during persistent infection of HEp-2 cells. Infect Immun (2001) 1.18
Comparison of sample preparation methods for detection of Chlamydia pneumoniae in bronchoalveolar lavage fluid by PCR. J Clin Microbiol (1994) 1.17
Antigenic and molecular analyses of different Chlamydia pneumoniae strains. J Clin Microbiol (1997) 1.16
Metabolic syndrome: the danger signal in atherosclerosis. Vasc Health Risk Manag (2006) 1.13
Characterization of Chlamydia pneumoniae persistence in HEp-2 cells treated with gamma interferon. Infect Immun (2001) 1.13
Effects of two antibiotic regimens on course and persistence of experimental Chlamydia pneumoniae TWAR pneumonitis. Antimicrob Agents Chemother (1995) 1.12
Chlamydia pneumoniae and atherosclerosis. Heart (1999) 1.11
Infection of human endothelial cells with Chlamydia pneumoniae stimulates transendothelial migration of neutrophils and monocytes. Infect Immun (1999) 1.11
Immunohistochemical localization of defensin in human coronary vessels. Am J Pathol (1997) 1.11
Characterization of a strain of Chlamydia pneumoniae isolated from a coronary atheroma by analysis of the omp1 gene and biological activity in human endothelial cells. Infect Immun (1998) 1.10
Comparison of an industry-derived LCx Chlamydia pneumoniae PCR research kit to in-house assays performed in five laboratories. J Clin Microbiol (2002) 1.09
De Novo induction of atherosclerosis by Chlamydia pneumoniae in a rabbit model. Infect Immun (1999) 1.09
Involvement of Chlamydia pneumoniae in atherosclerosis: more evidence for lack of evidence. J Clin Microbiol (2005) 1.08
Infectious causes of chronic inflammatory diseases and cancer. Emerg Infect Dis (1998) 1.07
The expression and functions of toll-like receptors in atherosclerosis. Mediators Inflamm (2010) 1.07
Influenza virus infection and risk of acute myocardial infarction. Inflammation (2008) 1.07
Multiplex polymerase chain reaction for the simultaneous detection of Mycoplasma pneumoniae, Chlamydia pneumoniae, and Chlamydia psittaci in respiratory samples. J Clin Pathol (1999) 1.05
Chlamydia pneumoniae induces inflammatory changes in the heart and aorta of normocholesterolemic C57BL/6J mice. Infect Immun (2000) 1.01
Chlamydia pneumoniae infection of human endothelial cells induces proliferation of smooth muscle cells via an endothelial cell-derived soluble factor(s). Infect Immun (1999) 1.01
Evolutionary relationships among members of the genus Chlamydia based on 16S ribosomal DNA analysis. J Bacteriol (1997) 1.00
Reliability of nested PCR for detection of Chlamydia pneumoniae DNA in atheromas: results from a multicenter study applying standardized protocols. J Clin Microbiol (2002) 1.00
Inhibition of Chlamydia pneumoniae replication in human aortic smooth muscle cells by gamma interferon-induced indoleamine 2, 3-dioxygenase activity. Infect Immun (2000) 0.98
Chlamydia pneumoniae serology: importance of methodology in patients with coronary heart disease and healthy individuals. J Clin Microbiol (2001) 0.96
Infection and Atherosclerosis Development. Arch Med Res (2015) 0.96
Are reactive oxygen species always detrimental to pathogens? Antioxid Redox Signal (2013) 0.95
Survival of Chlamydia pneumoniae-infected Mono Mac 6 cells is dependent on NF-kappaB binding activity. Infect Immun (2001) 0.94
Experimental rabbit models of Chlamydia pneumoniae infection. Am J Pathol (1996) 0.94
cDNA array analysis of altered gene expression in human endothelial cells in response to Chlamydia pneumoniae infection. Infect Immun (2001) 0.94
Effect of Chlamydia trachomatis infection on atherosclerosis in apolipoprotein E-deficient mice. Infect Immun (2000) 0.93
Is Chlamydia pneumoniae infection a risk factor for age related macular degeneration? Br J Ophthalmol (2003) 0.92
Cytokines induce indoleamine 2,3-dioxygenase expression in human atheroma-asociated cells: implications for persistent Chlamydophila pneumoniae infection. Infect Immun (2002) 0.92
Chlamydia pneumoniae antigens, rather than viable bacteria, persist in atherosclerotic lesions. J Clin Pathol (2000) 0.91
T lymphocyte lines isolated from atheromatous plaque contain cells capable of responding to Chlamydia antigens. Clin Exp Immunol (2000) 0.90
Chlamydia pneumoniae in atheroma: consideration of criteria for causality. J Clin Pathol (1998) 0.90
Isolation and characterization of a gene encoding a Chlamydia pneumoniae 76-kilodalton protein containing a species-specific epitope. Infect Immun (1994) 0.90
Tissue MicroArray (TMA) analysis of normal and persistent Chlamydophila pneumoniae infection. BMC Infect Dis (2006) 0.89
Infectious burden: a new risk factor and treatment target for atherosclerosis. Infect Disord Drug Targets (2010) 0.89
Hepatitis B virus infection and coronary atherosclerosis: results from a population with relatively high prevalence of hepatitis B virus. World J Gastroenterol (2005) 0.88
Non-detection of Chlamydia species in carotid atheroma using generic primers by nested PCR in a population with a high prevalence of Chlamydia pneumoniae antibody. BMC Infect Dis (2001) 0.86
Persistent Chlamydia pneumoniae infection of cardiomyocytes is correlated with fatal myocardial infarction. Am J Pathol (2007) 0.86
Chlamydia pneumoniae enhances cytokine-stimulated human monocyte matrix metalloproteinases through a prostaglandin E2-dependent mechanism. Infect Immun (2005) 0.85
Detection of Chlamydiae pneumoniae but not Helicobacter pylori DNA in atherosclerosis plaques. Dig Dis Sci (2003) 0.85
Chlamydia pneumoniae antibodies are associated with an atherogenic lipid profile. Heart (1999) 0.85
Respiratory infection in lipid-fed rabbits enhances sudanophilia and the expression of VCAM-1. Am J Pathol (1997) 0.85
Host cell responses to Chlamydia pneumoniae in gamma interferon-induced persistence overlap those of productive infection and are linked to genes involved in apoptosis, cell cycle, and metabolism. Infect Immun (2007) 0.84
Viral and bacterial DNA in carotid atherosclerotic lesions. Eur J Clin Microbiol Infect Dis (2003) 0.83
In vitro infection of smooth muscle cells by Chlamydia pneumoniae. Infect Immun (1997) 0.83
Antibodies to 60-kilodalton heat shock protein and outer membrane protein 2 of Chlamydia pneumoniae in patients with coronary heart disease. Clin Diagn Lab Immunol (2002) 0.83
Heat shock proteins 60 and 70 specific proinflammatory and cytotoxic response of CD4+CD28null cells in chronic kidney disease. Mediators Inflamm (2013) 0.82
Chlamydia pneumoniae infection increases adherence of mouse macrophages to mouse endothelial cells in vitro and to aortas ex vivo. Infect Immun (2007) 0.82
Expression and Localization of Predicted Inclusion Membrane Proteins in Chlamydia trachomatis. Infect Immun (2015) 0.82
Microbes, inflammation and atherosclerosis: will old pathology lessons guide new therapies? Trans Am Clin Climatol Assoc (2001) 0.82
Laboratory diagnosis of persistent human chlamydial infection. Front Cell Infect Microbiol (2013) 0.82
Distribution of Chlamydia pneumoniae DNA in atherosclerotic carotid arteries: significance for sampling procedures. J Clin Microbiol (2003) 0.81
Chlamydia pneumoniae replicates in Kupffer cells in mouse model of liver infection. World J Gastroenterol (2006) 0.81
Reactions of polyclonal and neutralizing anti-p54 monoclonal antibodies with an isolated, species-specific 54-kilodalton protein of Chlamydia pneumoniae. Clin Diagn Lab Immunol (1997) 0.81
Glycemic control in type 2 diabetes mellitus prevents coronary arterial wall infection. ARYA Atheroscler (2014) 0.81
Prevalence of specific antibodies to Chlamydia pneumoniae in Korea. J Clin Microbiol (1998) 0.81
Can an antibiotic (macrolide) prevent Chlamydia pneumoniae-induced atherosclerosis in a rabbit model? Clin Diagn Lab Immunol (1999) 0.81
Production of Chlamydia pneumoniae proteins in Bacillus subtilis and their use in characterizing immune responses in the experimental infection model. Clin Diagn Lab Immunol (2003) 0.80
Evaluation of five DNA extraction methods for purification of DNA from atherosclerotic tissue and estimation of prevalence of Chlamydia pneumoniae in tissue from a Danish population undergoing vascular repair. BMC Microbiol (2003) 0.80
A single infection with Chlamydia pneumoniae is sufficient to exacerbate atherosclerosis in ApoE deficient mice. Cell Immunol (2015) 0.79
Immunization with a MOMP-based vaccine protects mice against a pulmonary Chlamydia challenge and identifies a disconnection between infection and pathology. PLoS One (2013) 0.79
Increased incidence of cytomegalovirus but not Chlamydia pneumoniae in atherosclerotic lesions of arteries of lower extremities from patients with diabetes mellitus undergoing amputation. J Clin Pathol (2003) 0.79
Amalgamation of Chlamydia pneumoniae inclusions with lipid droplets in foam cells in human atherosclerotic plaque. Virchows Arch (2008) 0.79
Oral azithromycin in extended dosage schedule for chronic, subclinical Chlamydia pneumoniae infection causing coronary artery disease: a probable cure in sight? Results of a controlled preliminary trial. Int J Gen Med (2012) 0.78
Atherosclerosis Induced by Chlamydophila pneumoniae: A Controversial Theory. Interdiscip Perspect Infect Dis (2013) 0.78
Genome-wide analysis of Chlamydophila pneumoniae gene expression at the late stage of infection. DNA Res (2008) 0.78
Simplified preparation of human arterial sections for PCR analysis of Chlamydia pneumoniae and human DNA. Mol Pathol (1999) 0.77
Immunologic relationship between genital TRIC, lymphogranuloma venereum, and related organisms in a new microtiter indirect immunofluorescence test. Am J Ophthalmol (1970) 10.68
New knowledge of chlamydiae and the diseases they cause. J Infect Dis (1975) 9.35
A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections. N Engl J Med (1986) 8.03
Primary isolation of TRIC organisms in HeLa 229 cells treated with DEAE-dextran. J Infect Dis (1972) 6.85
A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR. J Infect Dis (1990) 6.52
Human serology in Chlamydia trachomatis infection with microimmunofluorescence. J Infect Dis (1974) 6.18
Immunotyping of Chlamydia trachomatis with monoclonal antibodies. J Infect Dis (1985) 5.29
Chlamydia pneumoniae (TWAR). Clin Microbiol Rev (1995) 4.93
Interaction of a liver-specific nuclear factor with the fibrinogen and alpha 1-antitrypsin promoters. Science (1987) 4.59
Reliability of DSM-IV anxiety and mood disorders: implications for the classification of emotional disorders. J Abnorm Psychol (2001) 4.53
Current and lifetime comorbidity of the DSM-IV anxiety and mood disorders in a large clinical sample. J Abnorm Psychol (2001) 4.30
Characterization of Campylobacter-like organisms isolated from homosexual men. J Infect Dis (1984) 4.23
New and emerging etiologies for community-acquired pneumonia with implications for therapy. A prospective multicenter study of 359 cases. Medicine (Baltimore) (1990) 4.04
Further classification of TRIC agents from ocular trachoma and other sources by the mouse toxicity prevention test. Am J Ophthalmol (1967) 3.63
Importance of reinfection in the pathogenesis of trachoma. Rev Infect Dis (1986) 3.50
Antimicrobial activity of several antibiotics and a sulfonamide against Chlamydia trachomatis organisms in cell culture. Antimicrob Agents Chemother (1977) 3.34
Current knowledge on Chlamydia pneumoniae, strain TWAR, an important cause of pneumonia and other acute respiratory diseases. Eur J Clin Microbiol Infect Dis (1989) 3.15
Identification of a new group of Chlamydia psittaci strains called TWAR. J Clin Microbiol (1986) 3.11
Fatal air embolism during dental implant surgery: a report of three cases. Can J Anaesth (1990) 3.04
Simplified microimmunofluorescence test with trachoma-lymphogranuloma venereum (Chlamydia trachomatis) antigens for use as a screening test for antibody. J Clin Microbiol (1975) 3.03
Pneumonia associated with the TWAR strain of Chlamydia. Ann Intern Med (1987) 3.00
Three new immunologic types of trachoma-inclusion conjunctivitis organisms. J Immunol (1973) 2.96
A simplified method for immunological typing of trachoma-inclusion conjunctivitis-lymphogranuloma venereum organisms. Infect Immun (1973) 2.93
Detection of Chlamydia pneumoniae TWAR in human coronary atherectomy tissues. J Infect Dis (1995) 2.90
Characterization of the new Chlamydia agent, TWAR, as a unique organism by restriction endonuclease analysis and DNA-DNA hybridization. J Clin Microbiol (1987) 2.78
Immunotypes of Chlamydia trachomatis isolates in Seattle, Washington. Infect Immun (1983) 2.76
A sensitive cell line, HL cells, for isolation and propagation of Chlamydia pneumoniae strain TWAR. J Infect Dis (1990) 2.74
Trachoma vaccine studies in monkeys. Am J Ophthalmol (1967) 2.65
Influence of the normal menstrual cycle on vaginal tissue, discharge, and microflora. Clin Infect Dis (2000) 2.64
Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease. JAMA (1992) 2.61
Unique ultrastructure in the elementary body of Chlamydia sp. strain TWAR. J Bacteriol (1987) 2.61
An epidemic of mild pneumonia due to an unusual strain of Chlamydia psittaci. J Infect Dis (1985) 2.60
Mycoplasma pneumoniae pneumonia in an urban area. Five years of surveillance. JAMA (1970) 2.58
Compulsory community and involuntary outpatient treatment for people with severe mental disorders. Cochrane Database Syst Rev (2005) 2.50
Epidemiology of Mycoplasma pneumoniae infection in families. JAMA (1966) 2.49
Detection of Chlamydia pneumoniae by polymerase chain reaction. J Clin Microbiol (1992) 2.49
Factors affecting viability and growth in HeLa 229 cells of Chlamydia sp. strain TWAR. J Clin Microbiol (1988) 2.41
Increased frequency of serum antibodies to Chlamydia trachomatis in infertility due to distal tubal disease. Lancet (1982) 2.38
Immunochemical studies on chlamydial group antigen (presence of a 2-keto-3-deoxycarbohydrate as immunodominant group). J Immunol (1972) 2.37
Differentiation of TRIC and LGV organisms based on enhancement of infectivity by DEAE-dextran in cell culture. J Infect Dis (1972) 2.36
Detection of Chlamydia pneumoniae in coronary arterial fatty streaks and atheromatous plaques. S Afr Med J (1992) 2.28
Detection of Chlamydia pneumoniae in aortic lesions of atherosclerosis by immunocytochemical stain. Arterioscler Thromb (1993) 2.27
Three new serovars of Chlamydia trachomatis: Da, Ia, and L2a. J Infect Dis (1991) 2.26
Chlamydia pneumoniae (TWAR) in atherosclerosis of the carotid artery. Circulation (1995) 2.24
TRIC type K, a new immunologic type of Chlamydia trachomatis. J Immunol (1974) 2.22
Epidemics of pneumonia caused by TWAR, a new Chlamydia organism, in military trainees in Finland. J Infect Dis (1988) 2.15
Chlamydia pneumoniae (TWAR) in coronary arteries of young adults (15-34 years old). Proc Natl Acad Sci U S A (1995) 2.15
Failure to detect Chlamydia pneumoniae in coronary atheromas of patients undergoing atherectomy. J Infect Dis (1996) 2.12
Isolation of Chlamydia pneumoniae from a carotid endarterectomy specimen. J Infect Dis (1997) 2.06
In vitro drug susceptibility of Chlamydia sp. strain TWAR. Antimicrob Agents Chemother (1988) 1.99
Induction and repression of outer membrane proteins by anaerobic growth of Neisseria gonorrhoeae. Infect Immun (1987) 1.98
Formalinized Chlamydia trachomatis organisms as antigen in the micro-immunofluorescence test. J Clin Microbiol (1979) 1.96
Chlamydia pneumoniae and cardiovascular disease. Emerg Infect Dis (1999) 1.91
Evidence that Chlamydia pneumoniae causes pneumonia and bronchitis. J Infect Dis (1993) 1.89
Evidence of systemic dissemination of Chlamydia pneumoniae via macrophages in the mouse. J Infect Dis (1998) 1.89
A potency test for trachoma vaccine utilizing the mouse toxicity prevention test. Am J Ophthalmol (1967) 1.89
Ofloxacin treatment of Chlamydia pneumoniae (strain TWAR) lower respiratory tract infections. Am J Med (1990) 1.86
Serological response to Chlamydia pneumoniae infection. J Clin Microbiol (1990) 1.86
Characterization of the group antigen of Chlamydia trachomatis. Infect Immun (1971) 1.86
Chlamydia pneumoniae strain TWAR antibody and angiographically demonstrated coronary artery disease. Arterioscler Thromb (1991) 1.86
Pathogens and atherosclerosis: update on the potential contribution of multiple infectious organisms to the pathogenesis of atherosclerosis. Thromb Haemost (2011) 1.85
Murine models of Chlamydia pneumoniae infection and atherosclerosis. J Infect Dis (1997) 1.82
Distal tubal obstruction induced by repeated Chlamydia trachomatis salpingeal infections in pig-tailed macaques. J Infect Dis (1987) 1.76
Repeated Chlamydia trachomatis infection of Macaca nemestrina fallopian tubes produces a Th1-like cytokine response associated with fibrosis and scarring. Infect Immun (1997) 1.74
Chlamydia trachomatis immunotype J. J Immunol (1975) 1.73
Sexually transmitted diseases and tubal pregnancy. Sex Transm Dis (1991) 1.69
Serological response to Chlamydia pneumoniae in adults with coronary arterial fatty streaks and fibrolipid plaques. J Clin Microbiol (1993) 1.63
An epidemic of infections due to Chlamydia pneumoniae in military conscripts. Clin Infect Dis (1993) 1.63
Pneumococcal isolations from patients with pneumonia and control subjects in a prepaid medical care group. Am Rev Respir Dis (1975) 1.60
Viral and mycoplasmal pneumonia in a prepaid medical care group during an eight-year period. Am J Epidemiol (1973) 1.55
Chlamydia pneumoniae infection accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice. J Infect Dis (1999) 1.54
Antibiotic treatment of Chlamydia pneumoniae for secondary prevention of cardiovascular events. Circulation (1998) 1.53
Structural and antigenic analysis of Chlamydia pneumoniae. Infect Immun (1990) 1.52
Pneumonia due to Mycoplasma pneumoniae. Its incidence in the membership of a co-operative medical group. N Engl J Med (1966) 1.52
Isolation of cytomegalovirus from a cohort of 100 infants throughout the first year of life. Proc Soc Exp Biol Med (1969) 1.50
Depomedroxyprogesterone-induced hypoestrogenism and changes in vaginal flora and epithelium. Obstet Gynecol (2000) 1.50
Psychological interventions for symptomatic management of non-specific chest pain in patients with normal coronary anatomy. Cochrane Database Syst Rev (2005) 1.46
Past infection by Chlamydia pneumoniae strain TWAR and asymptomatic carotid atherosclerosis. Atherosclerosis Risk in Communities (ARIC) Study Investigators. Am J Med (1993) 1.44
AA amyloidosis in vaccinated growing chickens. J Comp Pathol (2013) 1.43
Field trial of a monovalent and of a bivalent mineral oil adjuvant trachoma vaccine in Taiwan school children. Am J Ophthalmol (1967) 1.43
Direct fluorescent monoclonal antibody stain for rapid detection of infant Chlamydia trachomatis infections. Pediatrics (1984) 1.43
Prevention of clinical and subclinical rubella infection. Efficacy of three HPV-77 derivative vaccines. Am J Dis Child (1969) 1.43
Chlamydia pneumoniae strain TWAR, Mycoplasma pneumoniae, and viral infections in acute respiratory disease in a university student health clinic population. Am J Epidemiol (1990) 1.42
Past use of an intrauterine device and risk of tubal pregnancy. Epidemiology (1993) 1.41
Pannus with experimental trachoma and inclusion conjunctivitis agent infection of Taiwan monkeys. Am J Ophthalmol (1967) 1.41
Sequence analysis of the major outer membrane protein gene of Chlamydia pneumoniae. Infect Immun (1991) 1.40
Seroepidemiology of Chlamydia pneumoniae TWAR infection in Seattle families, 1966-1979. J Infect Dis (1992) 1.39